Pfizer-BioNTech COVID-19 mRNA vaccine

TERMINATED · · SARS-CoV-2, COVID-19, Post-Acute COVID-19 Syndrome

Study discontinued due to questions of data validity and bias in data which would limit causal inference and estimation of vaccine effectiveness.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.